CA2224662A1 - Isolation d'une molecule d'acide nucleique codant smage-3, un precurseur d'antigene de rejet de tumeurs murines - Google Patents

Isolation d'une molecule d'acide nucleique codant smage-3, un precurseur d'antigene de rejet de tumeurs murines Download PDF

Info

Publication number
CA2224662A1
CA2224662A1 CA002224662A CA2224662A CA2224662A1 CA 2224662 A1 CA2224662 A1 CA 2224662A1 CA 002224662 A CA002224662 A CA 002224662A CA 2224662 A CA2224662 A CA 2224662A CA 2224662 A1 CA2224662 A1 CA 2224662A1
Authority
CA
Canada
Prior art keywords
smage
nucleic acid
acid molecule
tumor rejection
isolated nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002224662A
Other languages
English (en)
Inventor
Olivier Debacker
Thierry Boon-Falleur
Etienne Deplaen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Ludwig Institute for Cancer Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd filed Critical Ludwig Institute for Cancer Research Ltd
Publication of CA2224662A1 publication Critical patent/CA2224662A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

On décrit Smage-3, une molécule d'acide nucléique codant un précurseur d'antigène de rejet de tumeurs murines, cette molécule différant des molécules d'acide nucléique Smage décrites précédemment de par sa nature autosomique.
CA002224662A 1995-06-29 1996-06-18 Isolation d'une molecule d'acide nucleique codant smage-3, un precurseur d'antigene de rejet de tumeurs murines Abandoned CA2224662A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49651795A 1995-06-29 1995-06-29
US08/496,517 1995-06-29

Publications (1)

Publication Number Publication Date
CA2224662A1 true CA2224662A1 (fr) 1997-01-16

Family

ID=23972981

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002224662A Abandoned CA2224662A1 (fr) 1995-06-29 1996-06-18 Isolation d'une molecule d'acide nucleique codant smage-3, un precurseur d'antigene de rejet de tumeurs murines

Country Status (6)

Country Link
EP (1) EP0873350A4 (fr)
JP (1) JPH11508767A (fr)
AU (1) AU6283496A (fr)
CA (1) CA2224662A1 (fr)
WO (1) WO1997001574A1 (fr)
ZA (1) ZA965372B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69929310T2 (de) 1998-02-05 2006-08-03 Glaxosmithkline Biologicals S.A. Tumorassoziierte antigenderivate der mage-familie, nukleinsäuresequenzen die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
RU2421991C2 (ru) † 2006-02-23 2011-06-27 Фмк Корпорейшн Стабильные смеси микроинкапсулированных и неинкапсулированных пестицидов

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
AU668772B2 (en) * 1992-08-31 1996-05-16 Ludwig Institute For Cancer Research Isolated nonapeptide derived from mage-3 gene and presented by HLA-A1, and uses thereof

Also Published As

Publication number Publication date
EP0873350A4 (fr) 1999-06-30
AU6283496A (en) 1997-01-30
EP0873350A1 (fr) 1998-10-28
ZA965372B (en) 1998-01-16
JPH11508767A (ja) 1999-08-03
WO1997001574A1 (fr) 1997-01-16

Similar Documents

Publication Publication Date Title
JP3608788B2 (ja) Ｍａｇｅ−３遺伝子から誘導されてｈｌａ−ａ１により提示される単離されたノナペプチドおよびそれらの用途
KR100288749B1 (ko) 종양거부항원 전구체 mage-3을 코딩하는 분리된 핵산분자 및 그것의 사용
EP0690675B1 (fr) Acide nucleique codant pour un precurseur d'antigene de rejet de tumeur
EP0711173B1 (fr) Peptides isoles formant des complexes avec la molecule mhc du clone hla-c 10 et utilisation de ceux-ci
AU704934B2 (en) Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
US6222012B1 (en) Isolated nonapeptides presented by HLA molecules, and uses thereof
EP0711355B1 (fr) Methode de diagnostic d'une anomalie par mise en evidence de l'expression des precurseurs gage des antigenes de rejet des tumeurs
EP1361271B1 (fr) Nonapeptide isolé dérivé du gène MAGE-3 et présenté par HLA-A1, et ses utilisations
US5587289A (en) Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof
US6392016B1 (en) Isolated protein molecules which are members of the MAGE-B family
US5856091A (en) Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
US5759783A (en) Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene
CA2224662A1 (fr) Isolation d'une molecule d'acide nucleique codant smage-3, un precurseur d'antigene de rejet de tumeurs murines
EP0789591B1 (fr) Procede d'identification des individus atteints d'anomalie cellulaire
AU697527B2 (en) Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof
CA2165435C (fr) Nouveaux precurseurs d'antigenes pour le rejet des tumeurs et molecules d'acides nucleiques codant pour ces precurseurs

Legal Events

Date Code Title Description
FZDE Dead